Improving Motivation And Continuous Assessment In Engineering Classrooms Through Student Response Systems

The use of Student Response Systems (SRS) is highly recommended to encourage the active and meaningful learning of students in each lecture. SRS promotes the motivation of students and improves the system of continuous assessment. One of the most popular applications designed for SRS is Socrative (Socrative n.d.). The use of Socrative gives real meaning to continuous assessment, since the teacher has an easily manageable record of the evolution of their students‘learning and will help the teacher to schedule both formative and summative assessment. The application allows the detection of topics that each student may not have understood and determines the percentage of the entire class with the same difficulty. Beyond the use of Socrative as an evaluation instrument, sufficiently referenced, in this article we present different methodologies supported by SRS implemented in engineering studies at the University the Salamanca. The methodologies aim to promote autonomous work outside the classroom, and in face-to-face classes, to maintain the attention and lead the reasoning of the students to facilitate learning. The influence of the methodologies proposed by the authors on a series of indicators related to the motivation and commitment of the students to the subjects will be presented. To the best of our knowledge, most of the work on SRS have been applied to non-university educational levels and for assessment purposes and very few of them have applied SRS to undergraduate engineering studies. The novelty of this work lies in introducing new methodologies supported by SRS in university engineering studies

Innovación docente en la enseñanza de los Fundamentos Físicos de la Informática: un enfoque aplicado

Memoria ID-0316. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2014-2015

Diseño y fabricación de un cuadricóptero en la asignatura Electrónica de los Sistemas Mecánicos (Grado en Ingeniería Mecánica) mediante el acercamiento al Aprendizaje Basado en Proyectos

Memoria ID-0317. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2014-2015

Diseño de prácticas de laboratorio para la asignatura periféricos (Grado en Ingeniería Informática)

Memoria ID-0315. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2014-2015

Acción tutorial on-line mediante el uso de tabletas gráficas en el ámbito de la teoría de circuitos electrónicos

Memoria ID-034. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2018-2019

SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group

This is a multicenter prospective observational study that included a large cohort (n = 397) of allogeneic (allo-HSCT; (n = 311) and autologous (ASCT) hematopoietic stem cell transplant (n = 86) recipients who were monitored for antibody detection within 3–6 weeks after complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from February 1, 2021, to July 20, 2021. Most patients (n = 387, 97.4%) received mRNA-based vaccines. Most of the recipients (93%) were vaccinated more than 1 year after transplant. Detectable SARS-CoV-2-reactive antibodies were observed in 242 (78%) of allo-HSCT and in 73 (85%) of ASCT recipients. Multivariate analysis in allo-HSCT recipients identified lymphopenia < 1 × 109/ml (odds ratio [OR] 0.33, 95% confidence interval [95% CI] 0.16–0.69, p = .003), active graft versus host disease (GvHD; OR 0.51, 95% CI 0.27–0.98, p = .04) and vaccination within the first year of transplant (OR 0.3, 95% CI 0.15–0.9, p = .04) associated with lower antibody detection whereas. In ASCT, non-Hodgkin's lymphoma (NHL; OR 0.09, 95% CI 0.02–0.44, p = .003) and active corticosteroid therapy (OR 0.2, 95% CI 0.02–0.87, p = .03) were associated with lower detection rate. We report an encouraging rate of SARS-CoV-2-reactive antibodies detection in these severe immunocompromised patients. Lymphopenia, GvHD, the timing of vaccine, and NHL and corticosteroids therapy should be considered in allo-HSCT and ASCT, respectively, to identify candidates for SARS-CoV-2 antibodies monitoring.Peer reviewe

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

Prior studies of antibody response after full SARS-CoV-2 vaccination in hematological patients have confirmed lower antibody levels compared to the general population. Serological response in hematological patients varies widely according to the disease type and its status, and the treatment given and its timing with respect to vaccination. Through probabilistic machine learning graphical models, we estimated the conditional probabilities of having detectable anti-SARS-CoV-2 antibodies at 3–6 weeks after SARS-CoV-2 vaccination in a large cohort of patients with several hematological diseases (n= 1166). Most patients received mRNA-based vaccines (97%), mainly Moderna® mRNA-1273 (74%) followed by Pfizer-BioNTech® BNT162b2 (23%). The overall antibody detection rate at 3 to 6 weeks after full vaccination for the entire cohort was 79%. Variables such as type of disease, timing of anti-CD20 monoclonal antibody therapy, age, corticosteroids therapy, vaccine type, disease status, or prior infection with SARS-CoV-2 are among the most relevant conditions influencing SARS-CoV-2-IgG-reactive antibody detection. A lower probability of having detectable antibodies was observed in patients with B-cell non-Hodgkin’s lymphoma treated with anti-CD20 monoclonal antibodies within 6 months before vaccination (29.32%), whereas the highest probability was observed in younger patients with chronic myeloproliferative neoplasms (99.53%). The Moderna® mRNA-1273 compound provided higher probabilities of antibody detection in all scenarios. This study depicts conditional probabilities of having detectable antibodies in the whole cohort and in specific scenarios such as B cell NHL, CLL, MM, and cMPN that may impact humoral responses. These results could be useful to focus on additional preventive and/or monitoring interventions in these highly immunosuppressed hematological patients.REDCap is developed and supported by Vanderbilt Institute for Clinical and Translational Research. We thank the Spanish Society of Hematology (SEHH) for its support on the study. We sincerely want to thanks the invaluable aid of microbiology services for their commitment in SARS-CoV-2-reactive IgG antibody monitoring in these highly immunosuppressed patients from all participating centers. Finally, we also want to thank the patients, nurses, and study coordinators for their foremost contributions in this study.Peer reviewe

El reto de la inclusión de los Objetivos de Desarrollo Sostenible en la formación inicial de profesores de secundaria: creación del MOOC curso cero sobre educación y ODS, inclusión en asignaturas y en trabajos fin de máster

Memoria ID-041. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2021-2022